Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Feixiong Cheng and Yadi Zhou.
Feixiong Cheng
Connection Strength
4.333
Yadi Zhou
  1. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res Ther. 2021 06 09; 13(1):110.
    View in: PubMed
    Score: 0.950
  2. A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biol. 2020 11; 18(11):e3000970.
    View in: PubMed
    Score: 0.912
  3. Artificial intelligence in COVID-19 drug repurposing. Lancet Digit Health. 2020 12; 2(12):e667-e676.
    View in: PubMed
    Score: 0.903
  4. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020; 6:14.
    View in: PubMed
    Score: 0.872
  5. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19. Signal Transduct Target Ther. 2021 07 30; 6(1):292.
    View in: PubMed
    Score: 0.240
  6. The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine Observation. Front Neurosci. 2021; 15:606926.
    View in: PubMed
    Score: 0.233
  7. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning. J Proteome Res. 2020 11 06; 19(11):4624-4636.
    View in: PubMed
    Score: 0.223
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.